These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

124 related articles for article (PubMed ID: 30281416)

  • 21. Successful large gene augmentation of USH2A with non-viral episomal vectors.
    Toms M; Toualbi L; Almeida PV; Harbottle R; Moosajee M
    Mol Ther; 2023 Sep; 31(9):2755-2766. PubMed ID: 37337429
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Pseudoexon activation in disease by non-splice site deep intronic sequence variation - wild type pseudoexons constitute high-risk sites in the human genome.
    Petersen USS; Doktor TK; Andresen BS
    Hum Mutat; 2022 Feb; 43(2):103-127. PubMed ID: 34837434
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Antisense Oligonucleotide Rescue of Deep-Intronic Variants Activating Pseudoexons in the 6-Pyruvoyl-Tetrahydropterin Synthase Gene.
    Martínez-Pizarro A; Leal F; Holm LL; Doktor TK; Petersen USS; Bueno M; Thöny B; Pérez B; Andresen BS; Desviat LR
    Nucleic Acid Ther; 2022 Oct; 32(5):378-390. PubMed ID: 35833796
    [TBL] [Abstract][Full Text] [Related]  

  • 24. In vitro splicing analysis showed that availability of a cryptic splice site is not a determinant for alternative splicing patterns caused by +1G-->A mutations in introns of the dystrophin gene.
    Habara Y; Takeshima Y; Awano H; Okizuka Y; Zhang Z; Saiki K; Yagi M; Matsuo M
    J Med Genet; 2009 Aug; 46(8):542-7. PubMed ID: 19001018
    [TBL] [Abstract][Full Text] [Related]  

  • 25. A novel intronic mutation in SHOX causes short stature by disrupting a splice acceptor site: direct demonstration of aberrant splicing by expression of a minigene in HEK-293T cells.
    Danzig J; Levine MA
    J Pediatr Endocrinol Metab; 2012; 25(9-10):889-95. PubMed ID: 23426818
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Knockout of ush2a gene in zebrafish causes hearing impairment and late onset rod-cone dystrophy.
    Han S; Liu X; Xie S; Gao M; Liu F; Yu S; Sun P; Wang C; Archacki S; Lu Z; Hu X; Qin Y; Qu Z; Huang Y; Lv Y; Tu J; Li J; Yimer TA; Jiang T; Tang Z; Luo D; Chen F; Liu M
    Hum Genet; 2018 Oct; 137(10):779-794. PubMed ID: 30242501
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Defective pre-mRNA splicing in PKD1 due to presumed missense and synonymous mutations causing autosomal dominant polycystic disease.
    Gonzalez-Paredes FJ; Ramos-Trujillo E; Claverie-Martin F
    Gene; 2014 Aug; 546(2):243-9. PubMed ID: 24907393
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Spectrum of USH2A mutations in Scandinavian patients with Usher syndrome type II.
    Dreyer B; Brox V; Tranebjaerg L; Rosenberg T; Sadeghi AM; Möller C; Nilssen O
    Hum Mutat; 2008 Mar; 29(3):451. PubMed ID: 18273898
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Functional correction by antisense therapy of a splicing mutation in the GALT gene.
    Coelho AI; Lourenço S; Trabuco M; Silva MJ; Oliveira A; Gaspar A; Diogo L; Tavares de Almeida I; Vicente JB; Rivera I
    Eur J Hum Genet; 2015 Apr; 23(4):500-6. PubMed ID: 25052314
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Scrutinizing pathogenicity of the USH2A c.2276 G > T; p.(Cys759Phe) variant.
    Reurink J; de Vrieze E; Li CHZ; van Berkel E; Broekman S; Aben M; Peters T; Oostrik J; Neveling K; Venselaar H; Ramos MG; Gilissen C; Astuti GDN; Galbany JC; van Lith-Verhoeven JJC; Ockeloen CW; Haer-Wigman L; Hoyng CB; Cremers FPM; Kremer H; Roosing S; van Wijk E
    NPJ Genom Med; 2022 Jun; 7(1):37. PubMed ID: 35672333
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Intronic PAH gene mutations cause a splicing defect by a novel mechanism involving U1snRNP binding downstream of the 5' splice site.
    Martínez-Pizarro A; Dembic M; Pérez B; Andresen BS; Desviat LR
    PLoS Genet; 2018 Apr; 14(4):e1007360. PubMed ID: 29684050
    [TBL] [Abstract][Full Text] [Related]  

  • 32. In Vivo Assessment of Potential Therapeutic Approaches for USH2A-Associated Diseases.
    Pendse ND; Lamas V; Pawlyk BS; Maeder ML; Chen ZY; Pierce EA; Liu Q
    Adv Exp Med Biol; 2019; 1185():91-96. PubMed ID: 31884594
    [TBL] [Abstract][Full Text] [Related]  

  • 33. The effects of structure on pre-mRNA processing and stability.
    Soemedi R; Cygan KJ; Rhine CL; Glidden DT; Taggart AJ; Lin CL; Fredericks AM; Fairbrother WG
    Methods; 2017 Aug; 125():36-44. PubMed ID: 28595983
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Antisense therapeutics for neurofibromatosis type 1 caused by deep intronic mutations.
    Pros E; Fernández-Rodríguez J; Canet B; Benito L; Sánchez A; Benavides A; Ramos FJ; López-Ariztegui MA; Capellá G; Blanco I; Serra E; Lázaro C
    Hum Mutat; 2009 Mar; 30(3):454-62. PubMed ID: 19241459
    [TBL] [Abstract][Full Text] [Related]  

  • 35. In vitro and in vivo rescue of aberrant splicing in CEP290-associated LCA by antisense oligonucleotide delivery.
    Garanto A; Chung DC; Duijkers L; Corral-Serrano JC; Messchaert M; Xiao R; Bennett J; Vandenberghe LH; Collin RW
    Hum Mol Genet; 2016 Jun; 25(12):2552-2563. PubMed ID: 27106101
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Global control of aberrant splice-site activation by auxiliary splicing sequences: evidence for a gradient in exon and intron definition.
    Královicová J; Vorechovsky I
    Nucleic Acids Res; 2007; 35(19):6399-413. PubMed ID: 17881373
    [TBL] [Abstract][Full Text] [Related]  

  • 37. A KCNH2 branch point mutation causing aberrant splicing contributes to an explanation of genotype-negative long QT syndrome.
    Crotti L; Lewandowska MA; Schwartz PJ; Insolia R; Pedrazzini M; Bussani E; Dagradi F; George AL; Pagani F
    Heart Rhythm; 2009 Feb; 6(2):212-8. PubMed ID: 19187913
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Antisense oligonucleotide treatment for a pseudoexon-generating mutation in the NPC1 gene causing Niemann-Pick type C disease.
    Rodríguez-Pascau L; Coll MJ; Vilageliu L; Grinberg D
    Hum Mutat; 2009 Nov; 30(11):E993-E1001. PubMed ID: 19718781
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Effects of intronic mutations in the LDLR gene on pre-mRNA splicing: Comparison of wet-lab and bioinformatics analyses.
    Holla ØL; Nakken S; Mattingsdal M; Ranheim T; Berge KE; Defesche JC; Leren TP
    Mol Genet Metab; 2009 Apr; 96(4):245-52. PubMed ID: 19208450
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Effects of splice sites on the intron retention in histamine H3 receptors from rats and mice.
    Ding W; Lin L; Ren F; Zou H; Duan Z; Dai J
    J Genet Genomics; 2009 Aug; 36(8):475-82. PubMed ID: 19683670
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.